Sabra Health Care REIT (NASDAQ:SBRA) Releases FY 2024 Earnings Guidance

Sabra Health Care REIT (NASDAQ:SBRA) updated its FY 2024 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 1.360-1.390 for the period, compared to the consensus estimate of 1.380. The company issued revenue guidance of -. Sabra Health Care REIT also updated its FY24 guidance to $1.39-1.42 EPS.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the company. Scotiabank raised their price target on Sabra Health Care REIT from $14.00 to $15.00 and gave the company a sector perform rating in a report on Wednesday, May 15th. Truist Financial raised their price target on Sabra Health Care REIT from $15.00 to $16.00 and gave the company a buy rating in a report on Thursday, June 27th. Four equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of Moderate Buy and a consensus price target of $16.40.

Sabra Health Care REIT Trading Up 1.1 %

NASDAQ:SBRA traded up $0.18 during mid-day trading on Wednesday, hitting $16.66. The company had a trading volume of 3,425,483 shares, compared to its average volume of 1,999,099. Sabra Health Care REIT has a fifty-two week low of $11.73 and a fifty-two week high of $16.91. The business’s fifty day moving average is $15.37 and its two-hundred day moving average is $14.49. The company has a debt-to-equity ratio of 0.89, a quick ratio of 4.33 and a current ratio of 4.33. The firm has a market cap of $3.86 billion, a P/E ratio of 83.30, a P/E/G ratio of 2.61 and a beta of 1.24.

Insider Transactions at Sabra Health Care REIT

In other Sabra Health Care REIT news, Director Catherine Cusack purchased 7,000 shares of the company’s stock in a transaction dated Wednesday, May 22nd. The shares were bought at an average price of $14.43 per share, with a total value of $101,010.00. Following the completion of the transaction, the director now directly owns 46,385 shares in the company, valued at approximately $669,335.55. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.10% of the stock is currently owned by insiders.

Sabra Health Care REIT Company Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.